For særlig information vedrørende virkningen af samtidig administration af syrehæmmende midler, se produktresuméet for protease- hæmmeren, som administreres samtidig.
For specific information regarding the impact of co-administration of acid reducing agents, refer to the SmPC of the co-administered protease inhibitor.